Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × talazoparib × Clear all

Phase

Phase 1 16 Phase 2 8 Phase 1/2 6 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 21 Metformin 13 pembrolizumab 11 Biopsy 10 Radiotherapy 8 Cyclophosphamide 7 gallium 68 PSMA-11 6 Sirolimus 6 Nivolumab 6 Letrozole 6 Fluorouracil 6 Bevacizumab 6 Rituximab 5 Radiation 5 Granulocyte Colony-Stimulating Factor 5 Fluorodeoxyglucose F18 5 Etoposide 5 Temozolomide 4 Radiosurgery 4 Methotrexate 4 Ipilimumab 4 Indocyanine Green 4 Filgrastim 4 Doxorubicin 4 Cisplatin 4 Aspirin 4 poly ICLC 3 olaparib 3 fluciclovine F-18 3 durvalumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02316834 2022-02-24

POSITION

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡